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Controlled intracellular generation of reactive
oxygen species in human mesenchymal stem cells
using porphyrin conjugated nanoparticles†
Andrea S. Lavado,a Veeren M. Chauhan,a Amer Alhaj Zen,b Francesca Giuntini,c
D. Rhodri E. Jones,d Ross W. Boyle,e Andrew Beeby,f Weng C. Chan*b and
Jonathan W. Aylott*a
Nanoparticles capable of generating controlled amounts of intracellular reactive oxygen species (ROS),
that advance the study of oxidative stress and cellular communication, were synthesized by functionaliz-
ing polyacrylamide nanoparticles with zinc(II) porphyrin photosensitisers. Controlled ROS production was
demonstrated in human mesenchymal stem cells (hMSCs) through (1) production of nanoparticles func-
tionalized with varying percentages of Zn(II) porphyrin and (2) modulating the number of doses of exci-
tation light to internalized nanoparticles. hMSCs challenged with nanoparticles functionalized with
increasing percentages of Zn(II) porphyrin and high numbers of irradiations of excitation light were found
to generate greater amounts of ROS. A novel dye, which is transformed into ﬂuorescent 7-hydroxy-4-
triﬂuoromethyl-coumarin in the presence of hydrogen peroxide, provided an indirect indicator for cumu-
lative ROS production. The mitochondrial membrane potential was monitored to investigate the destruc-
tive eﬀect of increased intracellular ROS production. Flow cytometric analysis of nanoparticle treated
hMSCs suggested irradiation with excitation light signalled controlled apoptotic cell death, rather than
uncontrolled necrotic cell death. Increased intracellular ROS production did not induce phenotypic
changes in hMSC subcultures.
1. Introduction
Reactive oxygen species (ROS) form through conversion of
molecular oxygen, by either (Type I) electron transfer, to
produce superoxide, hydrogen peroxide (H2O2) and hydroxyl
radicals or, (Type II) energy transfer, to produce singlet
oxygen.1 At a cellular level ROS production is highly regulated,
typically through confinement of their production to specific
organelles, such as the mitochondria,2 and management of
overproduction with antioxidants.3 Controlled ROS production
is known to regulate processes, such as programmed cell
death,4 initiation of host defences to pathogens5 and pro-
duction of energy via the mitochondrial electron transport
chain.6 Uncontrolled ROS production can propagate chain
reactions that can cause irreversible damage to intracellular
nucleic acids,7 proteins8 and lipids9 that can result in cellular
necrosis,10 neoplastic mutations11 and neurodegenerative
disorders.12
The eﬀects of ROS on intracellular processes have been
investigated through exogenous addition of H2O2.
13,14
However, diﬀusion of H2O2 through cell membranes is
thought to be restricted,15 due to tightly regulated membrane
channels, such that the eﬀect of exogenous ROS on intracellu-
†Electronic supplementary information (ESI) available: Materials and experi-
mental methods for the synthesis of (1) positively charged alkyne functionalized
nanoparticles (2) Zn(II) and Cu(II) centred porphyrin (3); conjugating porphyrins
to alkyne-functionalized nanoparticles via click chemistry (4) nanoparticle
characterisation (size charge and fluorescence), (5) synthesis of BPTFMC (6)
hMSC collection, storage and preparation (7) delivery of porphyrin functiona-
lized nanoparticles (8) staining mitochondria, cumulative ROS production and
determination of nanoparticles subcellular localisation (9) fluorescence
microscopy and controlled irradiation of hMSCs (10) flow cytometry and con-
trolled irradiation using a custom built irradiator. In addition, results highlight-
ing: (1) nanoparticles emission spectra, size and charge, (2) BPTFMC
fluorescence response and (3) hMSCs following light irradiation using flow cyto-
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lar eﬀects can be misinterpreted.16 Therefore, artificially
stimulating intracellular ROS, independent of innate and
exogenous ROS, in a controlled manner would enhance the
understanding of how oxidative stress contributes to healthy
or diseased states. Research into the development of tools to
generate ROS in a controlled manner has gathered momen-
tum, such that a number of diﬀerent strategies have been
reported.17–21
Polyacrylamide nanoparticles are at the forefront of investi-
gating cellular microenvironments of interest.22 Due to their
(1) small size, (2) optical transparency, (3) large surface to
volume ratio, and (4) highly versatile matrix, which can be
readily engineered to control physicochemical parameters,
they can be delivered to biological systems with minimal per-
turbation.23 We and others have shown previously how poly-
acrylamide nanoparticles can be utilized as an analytical
tool24–27 to target subcellular spaces28–30 and provide a real-
time measurements of the role of key biological parameters
in situ.31 Polyacrylamide nanoparticles have also been used in
photodynamic therapy,32,33 an established therapeutic strategy
that is dependent on photo-excitable compounds (photosensi-
tisers) to promote ROS-mediated cell inactivation and tissue
damage following irradiation with visible light.34
This article describes the synthesis and characterization of
polyacrylamide nanoparticles conjugated to zinc(II) or copper
(II) complexed porphyrins that are capable of generating con-
trolled amounts of ROS upon irradiation with visible light.
Nanoparticles were doped with cationic chemical groups, to
improve sub-cellular localization and delivered to human
mesenchymal stem cells (hMSCs). hMSCs do not constitutively
produce ROS or have a role in phagocytosis and therefore are a
good candidate to study the eﬀects of cumulative ROS. Control
over ROS generation was demonstrated by: (1) attenuating the
percentage of porphyrins on the nanoparticle surface and (2)
modulating the number of light irradiation doses to the inter-
nalized nanoparticles. The degree of ROS production was visu-
alized through use of a newly synthesized dye, which is
chemically transformed into a fluorescent entity in the pres-
ence of ROS. The cytotoxic eﬀects and possible phenotypic
changes induced by intracellular ROS generation on hMSCs
were investigated using flow cytometry.
2. Results and discussion
2.1 Synthesis and characterisation of porphyrin
functionalized nanoparticles
Two diﬀerent porphyrins metal complexes, Zn(II) and Cu(II),
were utilised as part of this study, Scheme 1. The ability of Zn
(II) porphyrins to generate ROS upon irradiation with visible
light has been well characterised,35 whereas Cu(II) complexes
do not display phototoxicity.36 The diﬀerence in activity is due
to the intrinsic electronic properties of the metal–porphyrin
complex. The presence of metal ions in the porphyrin macro-
cycle favours intersystem crossing and allows the excited
species to reach a triplet state. For Zn(II) porphyrins, the triplet
state lifetime is long enough to allow energy transfer to mole-
cular oxygen, thus generating singlet oxygen, a Type II photo-
sensitisation. Subsequently, as a result of the detoxification of
endo/exoperoxide originating from singlet oxygen-mediated
damage, hydrogen peroxide is formed. In contrast, the triplet
state lifetime of Cu(II) porphyrins is short and quickly decays
back to the ground state, preventing the generation of singlet
oxygen by energy transfer.37 Due to the diﬀerences in activity,
the Cu(II) porphyrin functionalized nanoparticles were utilised
as a control, so that the photosensitising activity could be attrib-
uted to the Zn(II) porphyrin functionalized nanoparticles alone.
Porphyrins were covalently linked to nanoparticles via a
Cu(I)-catalysed alkyne–azide cycloaddition reaction.35 The
percentage of nanoparticle functionalization was determined
by titrating alkyne functionalized nanoparticles with porphyrin
azides. Nanoparticles saturated with porphyrin were con-
sidered to be 100% functionalized. Nanoparticles functiona-
lized with 5, 10 and 20% Zn(II) or Cu(II) porphyrins were
prepared with nanoparticle diameters centred at 80 nm and
positive surface charge to facilitate subcellular localisation
(zeta potential > +15 mV) (see ESI Fig. S2 and S3†).
2.2 Delivery of porphyrin functionalized nanoparticles
To determine the subcellular localisation of the nanoparticles,
analyses were performed on hMSCs treated with Zn(II) por-
phyrin (5%) functionalized nanoparticles, and stained with
LysoTracker® blue and MitoTracker® green. Fig. 1A shows a
representative merged channel image of Zn(II) porphyrin func-
tionalized nanoparticles delivered to hMSCs. The insets show
the individual channels; (Ai) brightfield, (Aii) LysoTracker®
(blue), (Aiii) MitoTracker® (green) and (Aiv) Zn(II) porphyrin
conjugated nanoparticles (red). Separation of the fluorescence
channels to observe co-localisation of Zn(II) porphyrin func-
tionalized nanoparticles with the mitochondria, Fig. 1B, and
Scheme 1 Chemical structure of azide functionalized cationic por-
phyrin with Zn(II) and Cu(II) metal centres.
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lysosomes, Fig. 1C, facilitates characterisation of the sub-
cellular location.
The lysosomes, as highlighted by LysoTracker® blue,
appear in punctate vesicles that are co-localised in regions
with Zn(II) porphyrin functionalized particles (Pearson’s corre-
lation coeﬃcient (PCC) = 0.318 Fig. 1B). The nanoparticles are
internalized eﬃciently as highlighted by the strong signal
observed in the red fluorescence channel (Fig. 1Aiv). The mito-
chondria, identified by MitoTracker® green, are distributed
throughout the cytoplasm and are also co-localised with Zn(II)
porphyrin conjugated nanoparticles (PCC = 0.216 Fig. 1C). The
images comprising Fig. 1 indicate porphyrin functionalized
nanoparticles are internalised and associate with lysosomes
and mitochondria. Endosomal/lysosomal escape is thought to
occur via disruption of osmotic gradients by surface amine func-
tional groups,38 whereas mitochondrial association is likely to
be a result of interaction between the positively charged nano-
particle and the negatively charged mitochondrial membrane.39
2.3 Fluorescence imaging of ROS production
A novel dye, 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-
(trifluoromethyl)-2H-chromen-2-one (BPTFMC), was used to
determine the ability of the Zn(II) porphyrin functionalized
nanoparticles to generate ROS. BPTFMC is transformed in the
presence of hydrogen peroxide (H2O2) to the fluorescent entity
7-hydroxy-4-trifluoromethyl-coumarin (HTFMC), Scheme 2 (see
ESI Fig. S6–S8†). Visualisation of HTFMC fluorescence in sub-
cellular spaces can therefore be utilised as an indirect indi-
cator for cumulative ROS production.
2.4 Controlled ROS generation in hMSCs
Controlled ROS production in hMSCs was demonstrated
through: (1) irradiation of internalised nanoparticles with
increasing percentages of Zn(II) porphyrin (5, 10 and 20%),
with a single dose of excitation light and (2) irradiation of
internalised nanoparticles, functionalized with 5% Zn(II) por-
phyrin, with repeated doses of excitation light.
The eﬀect of a single dose of excitation light on internalised
nanoparticles bearing 5, 10 and 20% of Zn(II) porphyrin was
investigated. hMSCs were treated with nanoparticle suspen-
sions after which they were thoroughly washed to remove non-
internalised nanoparticles then stained with BPTFMC and
MitoTracker® red; to observe ROS production events and
location of viable mitochondria in sub-cellular spaces,
respectively.
After irradiation with a single dose of light (512 μW, 8 mm2,
2 seconds), an increase in the fluorescence intensity from
HTFMC (green) was observed, which correlates with percen-
tage increases in Zn(II) porphyrin conjugated to the nano-
particle, Fig. 2. The extent of cytotoxicity caused by the ROS
production was demonstrated by the fluorescence response
from MitoTracker® red, which emits a fluorescence response
when bound to viable mitochondrial membranes with active
membrane potentials.40 Fig. 2 highlights the presence of a
‘blast zone’ within which substantial amounts of ROS has
been produced, whilst the number of cells with active mito-
chondrial membrane potentials has been considerably
reduced. The extent of the lethality of high percentages of
Zn(II) porphyrin is demonstrated by hMSCs treated with 20%
Zn(II) porphyrin, which show a clear perimeter between viable
Fig. 1 (A) Merged ﬂuorescence image of (Ai) bright-ﬁeld image of hMSCs treated with (Aii) LysoTracker® blue, (Aiii) MitoTracker® green and (Aiv)
Zn(II) porphyrin conjugated nanoparticles (red) (see ESI Fig. S6† for larger images of Ai–iv). Co-localisation analysis between (B) Zn(II) porphyrin con-
jugated nanoparticles and LysoTracker® blue, and (C) Zn(II) porphyrin conjugated nanoparticles and MitoTracker® green. Scale bar = 10 μm.
Scheme 2 Reaction between non-ﬂuorescent 7-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-4-(triﬂuoromethyl)-2H-chromen-2-one
(BPTFMC) and ROS producing ﬂuorescent 7-hydroxy-4-(triﬂuoro-
methyl)-2H-chromen-2-one (HTFMC). HTFMC peak excitation and
emission wavelengths are 340 nm and 500 nm, respectively.
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and non-viable cells. Therefore, the extent of ROS production
and consequential cytotoxicity, as indicated by enhanced
HTFMC and diminished MitoTracker® red fluorescence,
respectively, is profoundly influenced by increases in the per-
centage of porphyrin functionalization.
A single dose of excitation light produced subtle increases
in ROS for hMSCs treated with nanoparticles functionalized
with 5% Zn(II) porphyrin, Fig. 2. To investigate if ROS pro-
duction can be augmented in a controlled manner, interna-
lised nanoparticles functionalized with 5% Zn(II) porphyrin
were subjected to repeat doses of excitation light. hMSCs were
irradiated with a dose of excitation light every 5 minutes for
100 minutes. The progress of cellular events was captured at 5,
30, 60 and 100 minutes, corresponding to 1, 6, 12 and 20
irradiations, respectively, Fig. 3. hMSCs treated with 5% Cu(II)
functionalized porphyrins show no observable diﬀerences in
cellular morphology, increases in ROS production or cytotoxi-
city after 20 irradiations, as indicated by brightfield images,
absence of HTFMC and similarity of fluorescence emission
from MitoTracker® red across all time points, respectively.
This observation is also true for hMSCs treated with nano-
particles functionalized with 5% Zn(II) porphyrin after a single
dose of excitation light.
The first signs of ROS generation appear after 6 irradiations
for hMSCs treated with 5% Zn(II) functionalized nanoparticles,
Fig. 3 (green). At these low levels of ROS, there are no apparent
changes in cellular toxicity, as there are no noticeable changes
in cellular morphology or fluorescence intensity from Mito-
Tracker® red. After 12 irradiations, ROS production and its
cytotoxic eﬀects are evident, as the fluorescence intensity of
HTFMC is pronounced; the signal from the MitoTracker® red
begins to decrease and the first signs of apoptotic blebbing
can also be observed on cell surfaces (Fig. 3). For hMSCs
dosed with 20 irradiations of excitation light the signal from
HTFMC was intensified further, suggesting sub-cellular spaces
were being enriched with ROS. In addition, the MitoTracker®
red emission was greatly diminished, implying that the
number of active mitochondrial membrane potentials was
Fig. 2 Bright-ﬁeld and ﬂuorescence images of untreated hMSCs and
hMSCs treated with 5, 10 and 20% Zn(II) functionalized nanoparticles,
stained with BPTFMC and MitoTracker® red, irradiated with a single
dose of light. BPTFMC, in the presence of H2O2, is converted to ﬂuor-
escent HTFMC. Scale bar = 50 μm.
Fig. 3 Bright-ﬁeld and ﬂuorescence images of hMSCs with internalised
Cu(II) (control) and Zn(II) functionalized nanoparticles (photosensitiser)
and merged ﬂuorescence images of hMSCs stained with BPTFMC and
MitoTracker® red. Green and red channels are indicative of HTFMC ﬂu-
orescence and corresponding ROS production and active mitochondrial
membrane potentials and cell viability, respectively. Scale bar = 20 μm.
Paper Nanoscale
14528 | Nanoscale, 2015, 7, 14525–14531 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
A
ug
us
t 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
3/
10
/2
01
6 
14
:1
3:
05
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
reduced; and there also are more signs of a decline in cellular
viability, as bright field images showed signs of increases in
apoptotic blebbing, Fig. 3.
2.5 Eﬀects of controlled intracellular ROS generation on
hMSCs characterisation
Flow cytometry was employed to quantify the viability and any
phenotypic variation in hMSC populations treated with Zn(II)
porphyrin functionalized nanoparticles and after illumination
with repeated doses of light (produced using a custom
designed irradiator that replicated the power and wavelength
of excitation light used during fluorescence microscopy, see
ESI†). Cell viability, apoptosis (controlled cell death), necrosis
(uncontrolled cell death), and cellular diﬀerentiation were
investigated through the use of fluorescent probes. Apoptosis
was investigated using Annexin V Alexa Flour® 488, which
binds to cell surface markers that are translocated during
apoptosis.41 Whereas, necrosis was determined using the DNA
intercalator propidium iodide, which stains deteriorating cells
with permeable membranes.42 The eﬀect of intracellular ROS
on hMSCs phenotype was studied using fluorescent antibodies
for specific cell surface markers.43,44
Fig. 4 shows there are no significant diﬀerences in the per-
centage of apoptotic and necrotic cells for (1) untreated and
(2) Cu(II) porphyrin functionalized nanoparticle treated hMSC
populations, after irradiation with 5 to 20 doses of excitation
light (approximately 20% of the population express markers
for apoptotic events that can be attributed to cell death during
storage and thawing). However, hMSCs treated with Zn(II) por-
phyrin functionalized particles demonstrate statistically sig-
nificant increases in the population of apoptotic cells when
compared to (1) untreated and Cu(II) functionalized nano-
particle treated hMSCs (p < 0.05) and (2) after repeated
irradiation with excitation light (p < 0.001). Dosing hMSCs
with 5, 10, 15 and 20 irradiations of excitation light increases
the percentage of apoptotic cells to 29, 30, 37 and 44%,
respectively (n = 6). We postulate that the percentage of apopto-
tic cells does not increase at low irradiation levels due to the
natural antioxidant levels present in the cell (5 to 10
irradiations).45 However, once this antioxidant reservoir is
exhausted it is noticeable the percentage of apoptotic cells
increases linearly with light irradiations (10 to 20 irradiations).
Populations of untreated hMSCs and Cu(II) or Zn(II) por-
phyrin functionalized nanoparticles treated hMSCs contained
low levels of propidium iodine positive cells; less than 5% of
total population, Fig. 4. There were no significant diﬀerences
between the hMSC populations after repeated doses of exci-
tation light, from 5 to 20 irradiations. These findings suggest
repeated irradiation of internalised Zn(II) porphyrin functiona-
lized nanoparticles generate doses of ROS that signal hMSCs
to undergo controlled apoptotic cell death rather than un-
controlled necrotic cell death. These observations also mirror
findings observed in Fig. 3, which show signs of apoptotic
blebbing, rather than necrotic cell lysis.
Phenotypic characterisation of hMSCs was explored, by
labelling cell surface markers with fluorochome-conjugated
antibodies, after 20 irradiations of excitation light and two
cellular passages. Phenotypic characterisation of hMSCs
showed untreated hMSCs and, Cu(II) or Zn(II) porphyrin func-
tionalized nanoparticle treated hMSCs presented virtually
identical phenotypic profiles (see ESI Fig. S10 & S11†). These
results suggest that irradiation of Zn(II) porphyrin functiona-
lized nanoparticles and subsequent ROS generation does not
change the phenotype or induce senescence patterns in
hMSCs.
3. Conclusion
In summary, we have demonstrated that upon illumination
nanoparticles functionalized with Zn(II) porphyrin trigger
intracellular ROS production. The intracellular eﬀects of
enhanced ROS production were evidenced through visualisa-
tion using BPTFMC, which is transformed into fluorescent
HTFMC in the presence of H2O2, and observation of diminish-
ing mitochondrial membrane potentials, using MitoTracker®
red. Increases in: (1) the percentage of Zn(II) porphyrin conju-
gated to nanoparticles, from 5 to 20%, and (2) the number of
irradiations of excitation light, enhanced ROS production and
subsequent cytotoxicity. Controlled irradiation of Zn(II) por-
phyrin functionalized nanoparticles was found to signal apop-
tosis in hMSCs, but did not induce necrosis or phenotypic
changes in hMSC subcultures. The Zn(II) porphyrin functiona-
lized nanoparticles described in this article exhibit two key
advances: (1) the level of ROS can be modulated to a desired
oxidative stress level, through control of either photosensitiser
Fig. 4 Comparison of untreated (blue) and 5% Cu(II) (green) or 5% Zn(II)
(red) functionalized nanoparticle treated hMSC populations undergoing
apoptosis (Ap, solid) and necrosis (Nec, diagonal lines) after 5, 10, 15 and
20 irradiations of excitation light. Percentage of apoptosis and necrosis
was determined using ﬂow cytometry by staining apoptotic hMSCs with
Annexin V 488 and propidium iodide, respectively. Error bars represent
standard deviation from the mean (n = 6). One Way ANOVA *** = p <
0.001; one way ANOVA * = p < 0.05. P values less than 0.05 were con-
sidered statistically diﬀerent.
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concentration or light dose, and (2) they are applicable to vir-
tually all biological systems, as they operate independent of
specific cell enzymes to generate ROS. For this reason, we
anticipate porphyrin functionalized nanoparticles will prove to
be a valuable tool to generate controlled amounts of intracellu-
lar ROS to advance the study of cellular processes and disease
progression.
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